LFST · LifeStance Health Group, Inc.
$10.89
+0.08 (+0.74%)
At close · Jul 24
Market Cap
$4.23B
Shares
387.83M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.42B
+13.9%
FY2025
Net Income
$9.66M
+116.8%
FY2025
Operating Margin
1.7%
+4.2pp
FY2025
Operating Cash Flow
$146.15M
+36.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $1.64B – $1.68B | $1.49B | $1.42BG | $1.25B | $1.06B | $859.54M | $667.51M | $212.52M | |
| — | $388.1M | $382.2M | $363.06M | $410.79M | $377.99M | $433.73M | $41.06M | |
| — | $12.62M | $13.13M | $30.27M | $43.07M | $40.28M | $39.04M | $3.06M | |
| — | $41.7M | $41.62M | $40.68M | $37.37M | $28.92M | $15.09M | $3.04M | |
| — | $1.45B | $1.4B | $1.28B | $1.24B | $1.07B | $953.86M | $197.28M | |
| — | $44.83M | $24.15M | -$31.61M | -$189.13M | -$210.17M | -$286.35M | $15.24M | |
| — | — | 1.7% | -2.53% | -17.92% | -24.45% | -42.9% | 7.17% | |
| — | $86.52M | $65.77M | $9.06M | -$151.76M | -$181.26M | -$271.26M | $18.28M | |
| — | $10.38M | $11.66M | $26.54M | $21.22M | $19.93M | $38.91M | $5.41M | |
| — | -$11.24M | -$11.79M | -$26M | -$17.45M | -$22.56M | -$46.75M | -$7.37M | |
| — | $33.59M | $12.36M | -$57.61M | -$206.58M | -$232.73M | -$333.11M | $7.88M | |
| — | $10.4M | $2.7M | -$170K | -$20.32M | -$17.17M | -$25.91M | $2.21M | |
| — | $23.2M | $9.66M | -$57.44M | -$186.26M | -$215.56M | -$307.2M | $5.67M | |
| — | — | 0.68% | -4.59% | -17.64% | -25.08% | -46.02% | 2.67% | |
| — | $23.2M | $9.66M | -$57.44M | -$186.26M | -$215.56M | -$343.95M | -$58.9M | |
| — | $22.59M | $8.73M | -$58.82M | -$187.23M | -$212.29M | -$307.2M | $5.67M | |
| shares | — | — | 386.02M | 379.15M | 367.46M | 355.28M | 327.52K | — |
| shares | — | — | 391.14M | 379.15M | 367.46M | 355.28M | 327.52K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.89×
Medical Care Facilities median 1.26×
EV/EBIT
96.22×
Medical Care Facilities median 19.44×
P/E (TTM)
—
Medical Care Facilities median 15.43×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1845257
CUSIP
53228F101
13F (30d)
43 filings
43 filers
Visit website
Investor relations